Getting to Remission: Use of Aripiprazole for Incomplete Response in Late-Life Depression

OBJECTIVE: To determine the feasibility and safety of aripiprazole augmentation for incomplete response to sequential SSRI and SNRI pharmacotherapy in late-life depression. METHOD: This study was a 12-week open-label pilot study of 24 patients aged 65 and above (mean age 73.9) diagnosed with MDD who...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sheffrin, Meera, Driscoll, Henry P., Lenze, Eric J., Mulsant, Benoit H., Pollock, Bruce G., Miller, Mark D., Butters, Meryl A., Amanda Dew, Mary, Reynolds, Charles F.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886714/
https://ncbi.nlm.nih.gov/pubmed/19210951
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars